For instance, recent studies have revealed that increased ANGPTL4 expression is closely associated with the invasiveness and drug resistance of KRASG12D pancreatic cancer [5, 6], and researchers have explored the mechanisms of drug resistance in KRAS-mutant cancers [7]. The gene discussed is KRAS; the disease is cancer.